Pharmacokinetics of iontophoretic sumatriptan administration
AssigneeTeva Pharmaceuticals International GmbH
InventorsTerri B. Sebree, Mark Pierce, Carol O'neill
Life of this patent
Estimating the term…
Abstract
Improved pharmacokinetic profiles for the iontophoretic delivery of sumatriptan are described.
Claims13
A method for treating a sumatriptan responsive state in a human in need thereof, comprising iontophoretically delivering to said human an effective amount of sumatriptan, or a salt thereof, using a current of 4 mA or greater during a first portion of a treatment period for about one hour without substantially irritating said human's skin, such that said sumatriptan responsive state in said human is treated.
An iontophoretic patch designed to iontophoretically deliver to a human sumatriptan, or a salt thereof, using a current of 4 mA or greater during a first treatment period for about one hour, without substantially irritating said human's skin.
Dependencies are inferred from the claim text.